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LETTERS TO THE EDITOR
Prognostic Value of Heart
Rate Variability in
Idiopathic Dilated Cardiomyopathy
We read with interest the report by Fauchier et al. (1), regarding
the prognostic value of heart rate variability for sudden death and
major arrhythmic events in patients with idiopathic dilated cardio-
myopathy. Their results showed that a decrease in heart rate
variability was an independent predictor of arrhythmic events and
sudden death in idiopathic dilated cardiomyopathy. They sug-
gested that it was not previously demonstrated. However, Szabo et
al. (2) studied the prognostic value of heart rate variability in
chronic congestive heart failure secondary to idiopathic or ischemic
dilated cardiomyopathy. Their patient group consisted of 178
patients (40 with idiopathic dilated cardiomyopathy, mean ejection
fraction 28%). Four (10%) of the 40 patients had a sudden cardiac
death during a follow-up of 23 months. Prognostic factors for
sudden cardiac death were left ventricular ejection fraction ,27%
and standard deviation of the averages of NN intervals ,108 ms.
The authors reported that impairment of heart rate variability
variables was correlated with an increased risk of cardiac death and
that heart rate variability appeared to have independent prognostic
value in congestive heart failure. In the study of Faucher et al., 116
patients with idiopathic dilated cardiomyopathy (ejection fraction
34 6 12%, mean follow-up 53 6 39 months) were investigated.
Seven patients (6%) had a sudden cardiac death.
In our opinion, despite the small group and the short follow-up,
the results of the study of Szabo et al. should have been taken into
consideration in Fauchier et al.’s study.
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REPLY
In response to the letter by Eryonucu et al., we considered with
great interest the report by Szabo et al. (1). We are in absolute
disagreement with Eryonucu about the prognostic value demon-
strated in this study for the specific end point of sudden death (1).
In this brief report, it was clearly stated that a low left ventricular
ejection fraction was the only predictor of sudden death in this
series of patients with congestive heart failure due to ischemic or
idiopathic dilated cardiomyopathy, with a follow-up time half of
that in our study (2). A decrease in heart rate variability was not a
predictor of sudden death nor was it included in the univariate or
multivariate analysis (Table 2). Moreover, we took into account
the occurrence of major arrhythmic events (sustained ventricular
tachycardia or ventricular fibrillation), whereas these events were
not considered by Szabo et al. In view of the several mechanisms
of sudden death in congestive heart failure, we consider that the
mixed end point of “sudden death or major arrhythmic events” is
probably the most specific one if there is a mechanism of
ventricular tachyarrhythmia that may be adequately treated by an
implantable cardioverter-defibrillator. Clearly, the results of our
study may be more helpful for the rationale of future prophylactic
studies about implantable cardioverter-defibrillator placement in
the particular situation of idiopathic dilated cardiomyopathy.
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Coronary Flow Reserve Assessment
From Average Peak Velocity Profiles
Alone Must Be Judged With Caution
We enjoyed the study by Caiati et al. (1) on contrast-enhanced
transthoracic second harmonic Doppler echocardiography with
adenosine for noninvasive coronary flow reserve (CFR) assessment,
which confirmed the very similar data from their recent study using
dipyridamole (2). Although the results are interesting, we would
like to comment on methodologic issues.
First, it should be emphasized that the assessment of CFR by
using the ratio of hyperemic to basal peak velocity is not entirely
correct, as it relies on the assumption of an invariate shape of the
velocity profile. In fact, the error introduced by changes of the flow
velocity profile has been shown to be as high as 11% (3).
Second, the spatial resolution in this study does not allow vessel
visualization. No accurate CFR assessment can be done by velocity
information alone, without knowing the exact vessel size, unless
this variable cancels out because vessel size remains constant.
However, it is a well-documented fact (see, for example, reference
6 of the study [4]) that adenosine leads to significant coronary
dilation, severely affecting the relation between coronary flow
velocity and volumetric flow, thus introducing an error of up to
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